"Aiputuo Biology", an incubator of Nanjing University Institute of Artificial Intelligence Biomedicine, has provided novel coronavirin-related mutant proteins to help prevent and control the novel CORONAVIRUS in Nanjing.

Nanjing Epoto Biomedical Technology Co., Ltd. is a biotechnology company mainly engaged in the research and development and production of recombinant protein reagents and provide technical services, the main products include recombinant protein and antibody, etc. Nanjing Epoto commitment to scientific research institutes, biochemical, pharmaceutical research and development enterprise, various kinds of biological research and development unit at home and abroad, pharmaceutical companies, in vitro diagnostic (IVD) companies, such as biotechnology products have good performance of recombinant virus subunits, recombinant cytokines, antibodies, IVD reagent core material and reagent solution.

Nanjing Epoto's protein synthesis technology, inherited from Moderna, is a world leader. Its products have been domestic well-known antibody companies, IVD companies and the majority of scientific research institutions of praise and recognition. The company is committed to supporting the anti-epidemic work in Nanjing, and provides a large number of raw materials for COVID-19 testing for IVD testing companies. The stock is sufficient and the price is favorable. Welcome to negotiate with us!

Contact Manager Lei 15195805780
Company address 9 / F, Building A, Talent Building, 10 Xinghuo Road, Jiangbei New Area, Nanjing city